1-2 of 2
Matsuo Yamamoto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Five-year interim analysis of multi-institutional collaborative study for estimating the persistence of treatment free remission in chronic myeloid leukemia after stopping tyrosine kinase inhibitor in Japan: J-SKI

Free
Naoto Takahashi, Shinya Kimura, Eri Matsuki, Takaaki Ono, Noriko Doki, Masaki Iino, Masashi Sawa, Yoshio Saburi, Kazunori Murai, Katsumichi Fujimaki, Shingo Kurahashi, Noriyoshi Iriyama, Takashi Onaka, Emiko Sakaida, Chikashi Yoshida, Keijiro Sato, Toshihiro Miyamoto, Tomoiku Takaku, Motoaki Shiratsuchi, Fumihiko Kimura, Seiichiro Katagiri, Matsuo Yamamoto, Akiko Saito, Itaru Matsumura
Journal: Blood
Blood (2025) 146 (Supplement 1): 5545.
https://doi.org/10.1182/blood-2025-5545
Published: 2025
Journal Articles

A Phase 2 study of sequential administration of gilteritinib after MEC chemotherapy in Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia in adults: Japan adult leukemia study group (JALSG) RR-FLT3-AML220 study

Free
Yuichi Ishikawa, Takahiro Yamauchi, Masashi Sawa, Tomomi Toubai, Yuho Najima, Tetsuya Nishida, Ichiro Kawashima, Yuna Katsuoka, Kazutaka Ozeki, Kensuke Usuki, Toru Kiguchi, Takeshi Saito, Satoru Takada, Ko Fujimoto, Shinya Sato, Tomoya Maeda, Hisayuki Yokoyama, Hiroki Uchida, Takumi Lee, Takashi Ishida, Matsuo Yamamoto, Akiko Saito, Emiko Sakaida, Yoshinobu Maeda, Itaru Matsumura, Yasushi Miyazaki, Hitoshi Kiyoi
Journal: Blood
Blood (2025) 146 (Supplement 1): 998.
https://doi.org/10.1182/blood-2025-998
Published: 2025